Apatinib-d8 free base, 1mg

Apatinib-d8 free base is a deuterium substitute of Apatinib free base. Apatinib free base is an orally bioavailable tyrosine kinase inhibitor that selectively targets VEGFR-2. Apatinib free base effectively inhibits Ret, c-Kit and c-Src activities, as well as cell phosphorylation of VEGFR-2, c-kit and PDGFRβ.

• Size: 1mg
• Purity: ≥90%
• Brand: Saint Michael
• Catalogue No.: ILA1831-1mg

For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.